Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PETN for secondary prevention of intrauterine growth restriction
DRKS00011374Phase 3Completed
- Sponsor
- Friedrich Schiller University Jena
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of isosorbide mononitrate in intrauterine growth restriction (IUGR) and Fetal malnutrition (FM) (2 arms), sponsored by Friedrich Schiller University Jena. Started Jun 2017; status: completed.
02
Drugs
isosorbide mononitrate
03
Conditions
intrauterine growth restriction (IUGR)Fetal malnutrition (FM)
Beyond the preview
Go deeper on DRKS00011374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00011374.